Insufficient scRNA-seq data for expression of TCF23 at single-cell level.
Insufficient scRNA-seq data for expression of TCF23 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 3591.95 | 180 / 180 | 57% | 1.89 | 247 / 430 |
uterus | 99% | 9551.56 | 169 / 170 | 10% | 4.49 | 46 / 459 |
spleen | 100% | 577.24 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 76% | 71.40 | 915 / 1204 | 0% | 0 | 0 / 0 |
stomach | 58% | 17.87 | 209 / 359 | 8% | 0.31 | 24 / 286 |
bladder | 52% | 14.86 | 11 / 21 | 2% | 0.18 | 11 / 504 |
breast | 43% | 13.74 | 198 / 459 | 4% | 0.09 | 41 / 1118 |
heart | 41% | 11.79 | 355 / 861 | 0% | 0 | 0 / 0 |
kidney | 35% | 16.70 | 31 / 89 | 2% | 0.04 | 18 / 901 |
thymus | 32% | 10.09 | 211 / 653 | 0% | 0.01 | 3 / 605 |
intestine | 27% | 8.67 | 261 / 966 | 4% | 0.10 | 19 / 527 |
prostate | 29% | 19.07 | 70 / 245 | 2% | 0.03 | 10 / 502 |
adrenal gland | 28% | 8.34 | 73 / 258 | 2% | 0.04 | 4 / 230 |
muscle | 25% | 5.96 | 204 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 25% | 17.05 | 330 / 1335 | 0% | 0 | 0 / 0 |
lung | 23% | 13.71 | 131 / 578 | 2% | 0.07 | 23 / 1155 |
skin | 22% | 6.62 | 400 / 1809 | 0% | 0.01 | 2 / 472 |
brain | 9% | 1.83 | 231 / 2642 | 13% | 0.48 | 92 / 705 |
pancreas | 3% | 0.47 | 9 / 328 | 15% | 0.31 | 26 / 178 |
esophagus | 13% | 3.37 | 185 / 1445 | 1% | 0.11 | 2 / 183 |
liver | 8% | 1.62 | 17 / 226 | 1% | 0.05 | 4 / 406 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0051148 | Biological process | negative regulation of muscle cell differentiation |
GO_0030154 | Biological process | cell differentiation |
GO_0046697 | Biological process | decidualization |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032502 | Biological process | developmental process |
GO_0007517 | Biological process | muscle organ development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000791 | Cellular component | euchromatin |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | TCF23 |
Protein name | Transcription factor 23 (TCF-23) (Class A basic helix-loop-helix protein 24) (bHLHa24) |
Synonyms | BHLHA24 |
Description | FUNCTION: Inhibits E-box-mediated binding and transactivation of bHLH factors. Inhibitory effect is similar to that of ID proteins. Inhibits the formation of TCF3 and MYOD1 homodimers and heterodimers. Lacks DNA binding activity. Seems to play a role in the inhibition of myogenesis (By similarity). . |
Accessions | ENST00000296096.6 Q7RTU1 |